These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 34093411)

  • 1. Serum Folate, Vitamin B12 Levels, and Systemic Immune-Inflammation Index Correlate With Motor Performance in Parkinson's Disease: A Cross-Sectional Study.
    Li S; Zhang Q; Gao Y; Nie K; Liang Y; Zhang Y; Wang L
    Front Neurol; 2021; 12():665075. PubMed ID: 34093411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible association between cerebral white matter atrophy and impaired performance of activities of daily living in patients with Parkinson's disease.
    Lu ZH; Chen YK; Fu XL; Chen QT; Yuan SL
    Folia Neuropathol; 2023; 61(3):266-272. PubMed ID: 37818687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Depression and Related Factors in Patients with Parkinson's Disease at High Altitude.
    Cao Y; Li G; Xue J; Zhang G; Gao S; Huang Y; Zhu A
    Neuropsychiatr Dis Treat; 2021; 17():1353-1362. PubMed ID: 33986595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of characteristics affecting instrumental activities of daily living in Parkinson's disease patients without dementia.
    Choi SM; Yoon GJ; Jung HJ; Kim BC
    Neurol Sci; 2019 Jul; 40(7):1403-1408. PubMed ID: 30931509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of vitamin B12 deficiency with metformin use in patients with type 2 diabetes treated in the largest tertiary care hospital in Qatar.
    Yousef Khan F; Yousif AB; Suliman A; Saleh AO; Magdi M; Alshurafa A; Abdelmoneim Hassan E; Ghazy A; Salameh OK; Abdallah A
    Qatar Med J; 2021; 2021(2):39. PubMed ID: 34540601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circulatory 25(OH)D and 1,25(OH)
    Ogura H; Hatip-Al-Khatib I; Suenaga M; Hatip FB; Mishima T; Fujioka S; Ouma S; Matsunaga Y; Tsuboi Y
    eNeurologicalSci; 2021 Dec; 25():100369. PubMed ID: 34611554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nonlinear Relationship Between Homocysteine and Mild Cognitive Impairment in Early Parkinson's Disease: A Cross-Sectional Study.
    Ouyang Q; Xu L; Zhang Y; Huang L; Li L; Yu M
    Neuropsychiatr Dis Treat; 2024; 20():913-921. PubMed ID: 38707522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduced plasma progranulin levels are associated with the severity of Parkinson's disease.
    Yao YN; Wang MD; Tang XC; Wu B; Sun HM
    Neurosci Lett; 2020 Apr; 725():134873. PubMed ID: 32112819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum BDNF discriminates Parkinson's disease patients with depression from without depression and reflect motor severity and gender differences.
    Huang Y; Huang C; Zhang Q; Wu W; Sun J
    J Neurol; 2021 Apr; 268(4):1411-1418. PubMed ID: 33179143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of serum Vitamin B12 level and related nutritional status among apparently healthy obese female individuals.
    Baltaci D; Deler MH; Turker Y; Ermis F; Iliev D; Velioglu U
    Niger J Clin Pract; 2017 Jan; 20(1):99-105. PubMed ID: 27958255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated Serum Homocysteine Levels Have Differential Gender-Specific Associations with Motor and Cognitive States in Parkinson's Disease.
    Bakeberg MC; Jefferson A; Riley M; Byrnes M; Ghosh S; Mastaglia FL; Horne MK; McGregor S; Stell R; Kenna J; Walters S; Hince D; Anderton RS
    Parkinsons Dis; 2019; 2019():3124295. PubMed ID: 31275543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia in patients with Parkinson's disease and relationship to vitamin B level.
    Shin HW; Sohn YH
    J Mov Disord; 2009 May; 2(1):33-6. PubMed ID: 24868350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutritional Status Associated with Molecular Biomarkers, Physiological Indices, and Clinical Severity in Parkinson's Disease Patients.
    Lin TK; Chang YY; Chen NC; Liou CW; Lan MY; Chen YF; Tsai CL
    Int J Environ Res Public Health; 2020 Aug; 17(16):. PubMed ID: 32784774
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased Serum S100β Concentration is Associated with Depression in Parkinson's Disease.
    Jiang G; Sheng C; Yan L; Wang Z; Wang Q; Chen R; Zhao Y
    Neuropsychiatr Dis Treat; 2023; 19():1865-1873. PubMed ID: 37663392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of psychiatric and other nonmotor symptoms on disability in Parkinson's disease.
    Weintraub D; Moberg PJ; Duda JE; Katz IR; Stern MB
    J Am Geriatr Soc; 2004 May; 52(5):784-8. PubMed ID: 15086662
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between Hypovitaminosis D and Nutritional Status with The Severity of Clinical Symptoms And Impaired Cognitive Function in Patients with Parkinson's Disease.
    Lien CY; Lu CH; Chang CC; Chang WN
    Acta Neurol Taiwan; 2021 Jun; 30(2)():63-73. PubMed ID: 34549391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperhomocysteinemia influenced malnutrition in Parkinson's disease patients.
    Tomic S; Pekic V; Popijac Z; Pucic T; Vinkovic MP; Kuric TG; Popovic Z
    Neurol Sci; 2018 Oct; 39(10):1691-1695. PubMed ID: 29961201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Higher vitamin B12 levels in neurodevelopmental disorders than in healthy controls and schizophrenia: A comparison among participants between 2 and 53 years.
    Hope S; Naerland T; Høiland AL; Torske T; Malt E; Abrahamsen T; Nerhus M; Wedervang-Resell K; Lonning V; Johannessen J; Steen NE; Agartz I; Stenberg N; Hundhausen T; Mørkrid L; Andreassen OA
    FASEB J; 2020 Jun; 34(6):8114-8124. PubMed ID: 32323402
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The need for levodopa as an end point of Parkinson's disease progression in a clinical trial of selegiline and alpha-tocopherol. Parkinson Study Group.
    LeWitt P; Oakes D; Cui L
    Mov Disord; 1997 Mar; 12(2):183-9. PubMed ID: 9087976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.